Alternatives to Henry Meds

The lowest advertised flat rate on this roster — $79/mo semaglutide, $129/mo tirzepatide, fully async — but no stated time-to-first-dose, and the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held.

Compounded semaglutide from $129 a month and tirzepatide from $199, held at the same price at every dose, plus a separate microdose line from $109 for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prices are published as starting points rather than a single rate, and the first-order discount of up to $140 is promotional.

The complete ladder is on the page before any intake, which almost nothing else here does: semaglutide $199 a month, $549 for three months, $999 for six, $1,788 for twelve; tirzepatide $299, $797, $1,494, $2,748. Read the long tiers correctly — each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 means paying a full year before the first box ships. Disclosure is above average where it counts. Andrew Meds LLC is named with a Houston address, and the practice that writes the prescription is named separately as Dr Tel X in Kennewick, Washington. Coverage is all fifty states and DC, enumerated rather than claimed, and there is an oral tirzepatide alongside the injections. The gaps: the compounding pharmacy is never named, no time to first dose is published, and a period you have partly used is not refunded.

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized.

A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and the compounding pharmacy isn't named.

The homepage and the pricing page tell different stories, and the pricing page is the kinder one. Every figure on the homepage carries the words "with annual prepay" — semaglutide starting at $169 a month, tirzepatide at $214 — which reads as though a year up front is the only way in. Open the full pricing table and each program has four tiers, the first labeled "Monthly · No commitment": semaglutide is $199 a month with nothing prepaid, tirzepatide $249. The prepay tiers are real savings rather than a gate — $2,028 buys a year of semaglutide at an effective $169. Everything is inside the figure: clinician evaluation, prescription, medication and shipping, with no separate consult fee. Nothing is charged unless a clinician prescribes; the card is authorized at intake as a hold, and if you are not prescribed you pay nothing. Review is typically within five hours and shipping three to five days. Coverage is 48 states plus DC, with Alaska and Mississippi named as the exclusions.

The best-documented supply chain on this board — seven pharmacies with addresses and phone numbers — attached to a shop that will not show you a single price until you have started a medical intake.

The most transparently tiered pricing found in this batch — as low as $99/mo semaglutide or $135/mo tirzepatide on the annual plan, with every tier itemized publicly — from a platform with a thin 36-review Trustpilot count so far.

Trellis Vitality is the cheapest genuinely-disclosed option on this page: $150 a month for compounded semaglutide and $199 for tirzepatide, month to month, with every dosage available at the same price and no membership fee, no consult fee and a $0 assessment. Commit for three or six months and those fall to $140/$133 and $189/$179. It names the pharmacy that compounds the medication — Vials Rx, described as a US state-licensed, cGMP-compliant facility — which is the disclosure most of its cheaper competitors skip, and it covers all 50 states with board-certified clinicians reviewing intake. The caveats are about what it doesn't sell and doesn't say. There is no FDA-approved brand option, no oral formulation, and none of its pricing appears on the homepage at all — you have to reach the GLP-1 product page to find a single number, which makes it look more opaque than it actually is. There is also no postpartum, breastfeeding or PCOS content anywhere.